http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104804042-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b33dd6f3ada81a293d6202f04929e5d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
filingDate 2014-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_844fee82e4b2013041a9b949d64c3442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb60dcb24cffa0cc71132d8ef20b1ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28fd66b334e4f40baaeccfe8c5e1e93f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3bbe38ec43370340d7a23407a02b948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bf9c152c6cc1f4625c43ab8e5268f0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_426e3337c8738cd57d01cc6e890ded92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b73df930fc73cf885c1bf0b6f7e5fba1
publicationDate 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104804042-A
titleOfInvention Nucleotide phosphonate compound, its pharmaceutical composition, preparation method and use
abstract The invention belongs to the field of medicine and chemical industry, and relates to a nucleotide phosphonate compound, its pharmaceutical composition, preparation method and application. Specifically, the present invention relates to a class of acyclic nucleotide phosphonate compounds represented by general formula I and their pharmaceutically acceptable inorganic or organic salts and preparation methods, as well as compositions containing compounds of general formula I . The compounds of the present invention can be used as active substances for the treatment and/or prevention of viral infectious diseases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107011382-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106317116-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108101943-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106167504-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108101943-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110938095-A
priorityDate 2014-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201311715-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104151360-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008005555-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009012292-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163971587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465749544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466858743

Total number of triples: 37.